Clinical trial
Open, Prospective, Uncontrolled, Multicentre Study to Evaluate The Safety and Efficacy of Multiple Applications of Liver Cell Suspension Into The Portal Vein in Children With Urea Cycle Disorders (UCDs)
NCT00718627 is registered in ClinicalTrials.gov with Cytonet GmbH & Co. KG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open, Prospective, Uncontrolled, Multicentre Study to Evaluate The Safety and Efficacy of Multiple Applications of Liver Cell Suspension Into The Portal Vein in Children With Urea Cycle Disorders (UCDs)
- Lead sponsor
- Cytonet GmbH & Co. KG
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 31, 2008
- Completion date
- November 30, 2015
- Enrollment
- 12 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
carbamoylphosphate synthetase i deficiency, citrullinemia, ornithine transcarbamylase deficiency, urea cycle disorders